Galectin Therapeutics shares owned by Northern Trust
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Northern Trust
from 13F filings
Historical chart of Northern Trust investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Northern Trust consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Northern Trust
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $242k | 101k | 2.39 |
| 2023-09-30 | $196k | 102k | 1.92 |
| 2023-06-30 | $147k | 102k | 1.44 |
| 2023-03-31 | $199k | 95k | 2.10 |
| 2022-12-31 | $96k | 85k | 1.13 |
| 2022-09-30 | $0 | 85k | 0.00 |
| 2022-06-30 | $0 | 90k | 0.00 |
| 2022-03-31 | $0 | 94k | 0.00 |
| 2021-12-31 | $0 | 94k | 0.00 |
| 2021-09-30 | $566k | 89k | 6.37 |
| 2021-06-30 | $613k | 96k | 6.37 |
| 2021-03-31 | $909k | 421k | 2.16 |
| 2020-12-31 | $1.0M | 453k | 2.23 |
| 2020-09-30 | $1.2M | 466k | 2.68 |
| 2020-06-30 | $1.5M | 494k | 3.06 |
| 2020-03-31 | $1.0M | 517k | 1.96 |
| 2019-12-31 | $1.4M | 490k | 2.85 |
| 2019-09-30 | $1.8M | 489k | 3.68 |
| 2019-06-30 | $542k | 134k | 4.04 |
| 2019-03-31 | $456k | 90k | 5.08 |
| 2018-12-31 | $296k | 87k | 3.41 |
| 2018-09-30 | $533k | 88k | 6.06 |
| 2018-06-30 | $550k | 87k | 6.35 |
| 2018-03-31 | $380k | 79k | 4.79 |
| 2017-12-31 | $275k | 84k | 3.29 |
| 2017-09-30 | $170k | 81k | 2.11 |
| 2017-06-30 | $190k | 75k | 2.53 |
| 2017-03-31 | $160k | 72k | 2.22 |
| 2016-12-31 | $40k | 45k | 0.89 |
| 2016-09-30 | $51k | 43k | 1.18 |
| 2016-06-30 | $61k | 43k | 1.41 |
| 2016-03-31 | $0 | 39k | 0.00 |
| 2015-12-31 | $75k | 43k | 1.75 |
| 2015-09-30 | $151k | 65k | 2.34 |
| 2015-06-30 | $495k | 183k | 2.71 |
| 2015-03-31 | $680k | 204k | 3.33 |
| 2014-12-31 | $707k | 204k | 3.47 |
| 2014-09-30 | $1.0M | 206k | 5.02 |
| 2014-06-30 | $889k | 64k | 13.88 |
| 2014-03-31 | $613k | 40k | 15.23 |
| 2013-12-31 | $281k | 35k | 7.93 |
| 2013-09-30 | $257k | 32k | 8.00 |